Medclair has received an order worth just over 3 MSEK for nitrous oxide destruction systems. The deal entails establishing a presence with a new customer and creates the conditions for continued expansion within the region. The order strengthens the company's position in Denmark, a market where Medclair has grown strongly in recent years.
Medclair's technology is currently installed at several Danish hospitals. The fact that yet another region now chooses the company confirms both the increasing demand and the great trust that has been built up within Danish healthcare. Furthermore, each new hospital establishment also opens up opportunities to broaden the collaboration over time to more departments and operations.
"Denmark is an important market for Medclair and this order is clear proof of the position we have built up over several years. We see a continued great interest in our solutions and good opportunities to continue growing in the market", says Jonas Lundh, CEO of Medclair.